What is ALIAXIN SV
ALIAXIN SV is a sterile, single 1 mL pre-filled syringe containing cross‑linked **hyaluronic acid (HA)**, designed for cosmetic use. As a dermal filler, it restores volume, smooths moderate-to-deep facial lines, and enhances facial contours.
- Formulation: Monophasic HA (~20–25 mg/ml), non-animal origin, cross-linked for durability and biocompatibility :contentReference[oaicite:1]{index=1}.
- Indications: Treats nasolabial folds, marionette lines, oral commissures, chin contouring, and lip augmentation (for patients ≥ 21 years) :contentReference[oaicite:2]{index=2}.
- Benefits: Immediate results, predictable integration, low allergy risk, and reversible with hyaluronidase if needed :contentReference[oaicite:3]{index=3}.
- Limitations: Effects typically last 6–12 months depending on area treated; not permanent :contentReference[oaicite:4]{index=4}.
ALIAXIN SV is a reliable and reversible tool for enhancing facial aesthetics, with a favorable safety profile and immediate efficacy.
How to use ALIAXIN SV
Administration requires a licensed professional using precise techniques and strict aseptic conditions.
- Preparation: Verify packaging integrity and expiry date; cleanse the skin with alcohol-based antiseptic; avoid quaternary ammonium solutions that may affect the filler :contentReference[oaicite:5]{index=5}.
- Needle handling: Typically uses 30G needles for precise placement; assemble securely onto syringe :contentReference[oaicite:6]{index=6}.
- Injection technique: Mid-to-deep dermal injection using linear threading, bolus, or fanning—depending on the area treated (e.g., nasolabial folds vs lips) :contentReference[oaicite:7]{index=7}.
- Volume: Generally 0.5–1 mL per session, tailored to patient anatomy and desired outcome :contentReference[oaicite:8]{index=8}.
- Post-injection: Light massage to distribute the gel, apply a cold compress to reduce swelling; advise avoiding makeup, alcohol, vigorous activity, and sun exposure for 24 hours :contentReference[oaicite:9]{index=9}.
- Follow-up: Schedule a review 2–4 weeks later to assess efficacy and consider minor touch-ups if needed.
- Patient briefing: Inform patients they may experience mild swelling, bruising, tenderness, and that full effects become apparent within a week.
Careful technique and patient education support safe, satisfactory outcomes.
Mode of Action ALIAXIN SV
ALIAXIN SV operates via mechanical volume restoration and biological interactions:
- Volume augmentation: Cross-linked HA gel fills and supports tissue, smoothing wrinkles and enhancing shape :contentReference[oaicite:10]{index=10}.
- Hydration: HA’s ability to bind water—up to a thousand times its weight—plumps and hydrates the skin, improving elastico-turgor :contentReference[oaicite:11]{index=11}.
- Integration: Monophasic formula ensures even integration, reducing the risk of lumps or nodules :contentReference[oaicite:12]{index=12}.
- Stimulation: HA presence may activate fibroblasts and promote collagen synthesis, enhancing skin quality over time :contentReference[oaicite:13]{index=13}.
- Degradation: The gel gradually breaks down via hyaluronidase enzymes and mechanical forces; results fade within 6–12 months depending on the treated area :contentReference[oaicite:14]{index=14}.
This combination of immediate support and longer-term tissue benefits delivers natural and lasting aesthetic improvements.
ALIAXIN SV Interactions ALIAXIN SV
ALIAXIN SV's localized use means systemic drug interactions are minimal, but certain local factors are important:
- Antiseptics: Avoid benzalkonium chloride; use alcohol-based prep to maintain HA integrity :contentReference[oaicite:15]{index=15}.
- Bleeding risk: Patients using NSAIDs, aspirin, or anticoagulants may have increased bruising; consider pausing medication before treatment :contentReference[oaicite:16]{index=16}.
- Other procedures: Avoid performing lasers, chemical peels, or micro-needling on the same area for at least a week post-injection :contentReference[oaicite:17]{index=17}.
- Hyaluronidase: An essential rescue agent; must be available in case of vascular compromise or over-correction :contentReference[oaicite:18]{index=18}.
Clear procedural planning and accurate patient history help minimize risks and improve outcomes.
Dosage of ALIAXIN SV
- Syringe volume: 1 mL HA per syringe at ~20–25 mg/mL concentration.
- Typical dosing:
- Nasolabial folds/marionette lines: 0.5–1 mL;
- Lips (augmentation/lip lines): 0.5 mL per lip;
- Chin/cheek: 0.5–1 mL depending on contouring need.
- Session plan: Usually a single session; possible minor touch-up after 2–4 weeks.
- Maintenance: Typically repeat every 6–12 months based on individual metabolism and lifestyle :contentReference[oaicite:19]{index=19}.
- Technique: Low-pressure microbolus or linear threading ensures precise placement and minimizes complications.
- Safety limit: Avoid overcorrection; follow conservative approach with incremental enhancement.
Dosing should be customized to patient needs, facial anatomy, and desired aesthetic results.
Possible side effects of ALIAXIN SV
- Common (< 7 days): Redness, swelling, hesitation, bruising, pain/tenderness, itching, heat at injection site—usually resolve within a week :contentReference[oaicite:20]{index=20}.
- Moderate (5–10%): Small lumps/nodules or asymmetry; often responsive to massage or minor hyaluronidase treatment :contentReference[oaicite:21]{index=21}.
- Rare (< 1%): Infections, sterile granulomas, hypersensitivity, vascular occlusion leading to necrosis—requires urgent intervention :contentReference[oaicite:22]{index=22}.
- Other: Mild headache or bleeding in intra-articular use (not applicable here).
Most reactions are mild and self-limiting. Prompt recognition and management of serious complications are critical for patient safety.
ALIAXIN SV Contraindications ALIAXIN SV
- Absolute:
- Known hypersensitivity to HA or syringe components (e.g., lidocaine) :contentReference[oaicite:23]{index=23};
- Active cutaneous infection/inflammation at treatment site :contentReference[oaicite:24]{index=24};
- Bleeding disorders or unmodifiable anticoagulation therapy :contentReference[oaicite:25]{index=25}.
- Relative:
- Pregnancy/breastfeeding—insufficient safety data :contentReference[oaicite:26]{index=26};
- Autoimmune disease—evaluate based on severity;
- History of keloids or pigmentation disorders—consider caution :contentReference[oaicite:27]{index=27}.
Thorough screening ensures safe and appropriate patient selection.
Storage of ALIAXIN SV
- Temperature: Store between 2–25 °C (36–77 °F); protect from freezing and excessive heat :contentReference[oaicite:28]{index=28}.
- Packaging: Keep syringe sealed in original blister until use—protect from light and moisture.
- Sterility: Use single-use only; discard unused portions post-injection.
- Expiry: Use before printed date; do not use expired or compromised product.
- Disposal: Dispose of syringe and needle as per medical waste regulations.
Proper storage preserves HA stability, sterility, and guarantees safe administration.
ALIAXIN SV features an exceptional active ingredient renowned for its potent effects, comprising Hyaluronic acid. This powerful formulation provides a superior solution for addressing diverse health concerns. With 0.025 concentration and an easily manageable Injection Solution for, it remains a preferred option for countless individuals seeking effective treatment.
Introduction
All you need to know about ALIAXIN SV .
Welcome to Dwaey, specifically on ALIAXIN SV page.
This medicine contains an important and useful components, as it consists of Hyaluronic acid.
ALIAXIN SV is available in the market in concentration 0.025 and in the form of Injection Solution for.
ROSE PHARMA SA is the producer of ALIAXIN SV and it is imported from SWITZERLAND,
The most popular alternatives of ALIAXIN SV are listed downward .
-
Active Substance
-
Size
-
Indications
- No indications available.
-
Type
-
Company
Frequently Asked Questions
ALIAXIN SV should be stored according to the instructions provided by ROSE PHARMA SA.
In general, it is recommended to store ALIAXIN SV in a cool, dry place, away from direct sunlight
and out of the reach of children.
The duration of treatment with ALIAXIN SV may vary depending on the condition being treated
and the guidance of your healthcare provider. It is important to follow the prescribed treatment
plan and continue taking ALIAXIN SV for the recommended duration, even if your symptoms improve.
If you have any concerns or questions about the duration of treatment, consult your healthcare provider.
It is important to check with your healthcare provider or read the medication label for specific
instructions regarding alcohol consumption while taking ALIAXIN SV. Some medications, including
ALIAXIN SV, may have interactions with alcohol that can reduce effectiveness, increase side
effects, or pose other risks to your health. It is best to follow the guidance provided by your
healthcare professional.
If you miss a dose of ALIAXIN SV, take it as soon as you remember. However, if it is close
to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing
schedule. Do not take a double dose to make up for a missed one unless advised by your healthcare provider.
No, do not stop taking ALIAXIN SV without consulting your healthcare provider, even if your
symptoms improve. It is important to complete the full course of treatment as prescribed. Stopping
the medication prematurely may lead to a relapse or incomplete resolution of the condition. If you
have concerns about the duration of treatment, consult your healthcare provider for guidance.
It is important to consult your healthcare provider before taking ALIAXIN SV if you are
pregnant or breastfeeding. They will be able to assess the potential risks and benefits based on your
specific situation. Please note that the safety and suitability of ALIAXIN SV during pregnancy
or breastfeeding may depend on the active substance [Active Substance], concentration 0.025,
and the specific recommendations of ROSE PHARMA SA.
The effects of ALIAXIN SV on your ability to drive or operate machinery can vary depending on
the active substance [Active Substance], concentration 0.025, and individual factors.
Some medications may cause drowsiness, dizziness, or other side effects that can impair your judgment
or coordination. It is important to read the medication label or consult your healthcare provider to
understand any potential effects on your ability to perform tasks that require alertness.
The instructions for taking ALIAXIN SV with or without food may vary depending on the medication
and the recommendations of ROSE PHARMA SA. Some medications may be more effective when taken with
food to enhance absorption or reduce stomach irritation, while others may need to be taken on an empty
stomach for optimal absorption. Read the medication label or consult your healthcare provider for specific instructions.
The use of ALIAXIN SV in children or elderly individuals may depend on various factors, including
the specific medication, type Injection Solution for, and the recommendations of ROSE PHARMA SA. Some
medications may have specific dosing instructions or precautions for these age groups. Consult your
healthcare provider or read the medication label for information regarding the safe and appropriate use
of ALIAXIN SV in children or elderly individuals.
Dwaey
All medical information published on the Dwaey website aims to increase medical awareness and health education among users. However, it is not a substitute for professional medical advice. Always consult with a specialist doctor. We strongly advise against using any information or medicine found on the site without referring to your healthcare provider.
Related Products
0 Comments